Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “BTC”

139 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 139 results

Testing effectiveness (Phase 2)UnknownNCT05822453
What this trial is testing

Gemcitabine Plus S1 and Tislelizumab in the First Line Therapy of Advanced Biliary Tract Carcinoma

Who this might be right for
Biliary Tract Carcinoma
Peking Union Medical College Hospital 20
Testing effectiveness (Phase 2)Study completedNCT03111732
What this trial is testing

Pembrolizumab, a Monoclonal Antibody Against PD-1, in Combination With Capecitabine and Oxaliplatin (CAPOX) in People With Advanced Biliary Tract Carcinoma (BTC)

Who this might be right for
Biliary Tract NeoplasmsCholangiocarcinomaBile Duct Cancer+2 more
National Cancer Institute (NCI) 11
Testing effectiveness (Phase 2)Active Not RecruitingNCT07654530
What this trial is testing

Sintilimab Combined With Ipilimumab (N01) Plus AG as First-line Therapy for uBTC.

Who this might be right for
Biliary Tract Cancers (BTC)
Tianjin Medical University Cancer Institute and Hospital 107
Testing effectiveness (Phase 2)Study completedNCT02821754
What this trial is testing

A Pilot Study of Combined Immune Checkpoint Inhibition in Combination With Ablative Therapies in Subjects With Hepatocellular Carcinoma (HCC) or Biliary Tract Carcinomas (BTC)

Who this might be right for
Biliary Tract NeoplasmsLiver CancerHepatocellular Carcinoma+2 more
National Cancer Institute (NCI) 54
Testing effectiveness (Phase 2)Looking for participantsNCT07398339
What this trial is testing

Cosiporfin Sodium for Injection Photodynamic Therapy

Who this might be right for
Biliary Tract Cancers (BTC)
Shanghai Guangsheng Biopharmaceutical Co., Ltd 30
Testing effectiveness (Phase 2)Study completedNCT03929666
What this trial is testing

A Safety and Efficacy Study of ZW25 (Zanidatamab) Plus Combination Chemotherapy in HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer

Who this might be right for
HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer
Jazz Pharmaceuticals 74
Post-approval studies (Phase 4)UnknownNCT02943031
What this trial is testing

The Effect of Individualized Precision Therapy Programs in Patients With BTC

Who this might be right for
Biliary Tract Neoplasms
RenJi Hospital 60
Not applicableLooking for participantsNCT07404202
What this trial is testing

A Multicenter, Non-interventional, Descriptive Study to Assess Assay Concordance of HER2 IHC Testing in Chinese Pan-tumor Patients

Who this might be right for
Pan-tumor(NSCLC, GYN Cancers, BTC and UC)
AstraZeneca 2,100
Not applicableLooking for participantsNCT07609641
What this trial is testing

Surgical Total Clearance Versus Extrahepatic Bile Duct Preservation for Biliary Tract Malignancies: A Single-Center, Randomized, Two-Arm, Prospective Phase II Clinical Trial

Who this might be right for
BTC
Tianjin Medical University Cancer Institute and Hospital 60
Testing effectiveness (Phase 2)Study completedNCT03531320
What this trial is testing

Study of D07001-Softgel Capsules in Subjects With Gastrointestinal Cancer in Dose-Escalation Phase and in Subjects With Biliary Tract Cancer in Dose-Expansion Phase

Who this might be right for
Gastrointestinal CancerBiliary Tract Cancer
InnoPharmax Inc. 19
Testing effectiveness (Phase 2)UnknownNCT05327582
What this trial is testing

An Open-label, Phase I/II Study of PLENA Regimen in Patients With Unresectable Pancreatic Cancer or BTC

Who this might be right for
Pancreatic CancerBiliary Tract Cancer
Chinese PLA General Hospital 65
Testing effectiveness (Phase 2)Looking for participantsNCT07433673
What this trial is testing

Gemcitabine, Cisplatin, Nab-paclitaxel (GAP) and Cemiplimab for Locally Advanced Biliary Tract Cancer (BTC)

Who this might be right for
Colon and Rectal Cancer
Columbia University 20
Early research (Phase 1)Looking for participantsNCT06270706
What this trial is testing

PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced or Metastatic Solid Tumor
Pliant Therapeutics, Inc. 124
Testing effectiveness (Phase 2)Study completedNCT03778593
What this trial is testing

FOLFIRINOX for 2nd-line Treatment of BTC

Who this might be right for
Biliary Tract Cancer
Dong-A University Hospital 34
Not applicableWithdrawnNCT00873132
What this trial is testing

BTC Neuropsychological Database

Who this might be right for
Brain Tumor
Duke University
Not applicableNot Yet RecruitingNCT07830628
What this trial is testing

Bile ctDNA Genomic Profiling and Concordance With Tumor Tissue in Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer (BTC)
CHA University 100
Not applicableLooking for participantsNCT06611345
What this trial is testing

Tumor-Treating Fields in Combination With Durvalumab and Gemcitabine/Cisplatin in Biliary Tract Cancers

Who this might be right for
Biliary Tract Cancers (BTC)
Jiangsu Healthy Life Innovation Medical Technology Co., Ltd 60
Not applicableLooking for participantsNCT07326137
What this trial is testing

A Prospective Observational Study of First-Line Systemic Therapy Combined With Celiac Plexus Blockade for Advanced Biliopancreatic Cancer With Pain

Who this might be right for
Advanced Biliary Tract Cancer(BTC)Advanced Pancreatic CancersCancer-related Pain
Tongji Hospital 103
Large-scale testing (Phase 3)Looking for participantsNCT07229625
What this trial is testing

A Phase III Study of SHR-8068 in Combination With Adebrelimab and Platinum-Containing Chemotherapy Versus Durvalumab in Combination With Platinum-Containing Chemotherapy as First-line Treatment for Advanced Biliary Tract Cancer (BTC)

Who this might be right for
Advanced Biliary Tract Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 604
Early research (Phase 1)Looking for participantsNCT04900818
What this trial is testing

Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors

Who this might be right for
Solid TumorAdvanced CancerMetastatic Cancer+5 more
I-Mab Biopharma US Limited 330
Next Page